Data Characteristics in this Domain
Pharmacoeconomics research uses diverse data sources. These include clinical trial reports, real-world evidence (RWE) databases, medical claims data, drug labels, guideline consensuses, and assessment reports from health technology assessment (HTA) agencies worldwide. Data update frequencies vary. Clinical trial data typically releases after study completion, while RWE databases may update quarterly or annually. Document structures often include standard sections like abstract, methods, results, and discussion in report-type documents. However, they contain numerous internal tables and figures. These involve core economic indicators such as Quality-Adjusted Life Years (QALY), Incremental Cost-Effectiveness Ratio (ICER), and disease burden. Common fields include drug name, indication, treatment regimen, treatment duration, costs (direct/indirect), efficacy indicators (OS, PFS, etc.), utility values, discount rates, and sensitivity analysis parameters. Units cover monetary units (USD, EUR, etc.), time units (years, months), percentages, and ratios. These often accompany confidence intervals or P-values.
Constraints on "Reference and Traceability" from these Characteristics
The complexity and diversity of pharmacoeconomics documents impose specific requirements on reference and traceability. First, multi-source heterogeneous data necessitates flexible document parsing strategies. This ensures effective processing of different formats (PDF, Word, Excel, HTML) and accurate extraction of key information. Second, high-density tabular and graphical data, including economic indicators, require structured parsing to identify and link this data with contextual text. For example, a specific ICER value may originate from particular clinical trial results and be limited by specific parameter settings. This dictates chunking must balance text coherence and data integrity. Finally, specialized terminology, abbreviations, and specific calculation methods common in reports require precise matching during retrieval and tracing. This enables tracing back to specific paragraphs or data points in original documents. This supports reliability verification and sensitivity analysis of results. This directly impacts the granularity of recall strategies and citation display.
Configuration Settings
| Configuration Item | Recommended Value | Rationale for this Value |
|---|---|---|
Chunk size | 800–1200 characters | Balances contextual completeness and retrieval efficiency. Ensures key economic indicators and their explanations are not truncated. |
Overlap Length | 150–250 characters | Ensures semantic continuity between adjacent segments. Prevents loss of critical information at segment boundaries. |
Recall count | Top 5–8 entries | Pharmacoeconomic analysis often requires more context to support complex logic. Appropriately increases the number of recalled items. |
Similarity threshold | Calibrate by actual measurement | For highly specialized terminology and numerically intensive content, testing is necessary to ensure accurate recall. |
citation Display Granularity | Paragraph Level | Pharmacoeconomic data and conclusions are often embedded in specific paragraphs. Paragraph-level traceability provides sufficient detail. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Parsing large clinical trial reports or complex HTA reports can be time-consuming. |
Three Common Mistakes
- Missing references or references pointing to inaccurate document locations: This occurs when document parsing fails to correctly identify data in tables or figures, leading to its detachment from related text, or when overly fine chunking cuts off critical information.
- Retrieval results containing numerous irrelevant or low-relevance citations: This happens because vector models may generalize insufficiently when processing highly specialized economic terminology and numerical values, leading to similarity calculation deviations.
- Large report processing timeouts, preventing knowledge base construction: This results from
PARSE_FILE_TIMEOUT_SECONDSbeing set too short. It cannot handle the large file sizes and complex structures common in pharmacoeconomics reports.
How to Confirm Correct Configuration
- Randomly select different types of pharmacoeconomics documents. Upload them and conduct Q&A tests. Check if references accurately point to specific paragraphs or tables in the original documents.
- For questions involving key economic indicators (e.g., ICER, QALY), verify if the recalled content includes these indicators and their contextual explanations.
- Attempt to query questions containing specialized terminology and abbreviations (e.g., QALY, ICER, PFS). Verify if recalled references precisely match and provide relevant information.
- Check knowledge base construction logs. Ensure no document processing failures occurred due to timeouts or parsing errors, especially for large and complex documents.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.